Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis-Reference-Cited by-同舟云学术

Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis

Published:2016-04 Issue:4 Volume:16 Page:431-440
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Kelly Ruth,Zoubiane Ghada,Walsh Desmond,Ward Rebecca,Goossens Herman

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference10 articles.

1. Non-prescription antimicrobial use worldwide: a systematic review;Morgan;Lancet Infect Dis,2011

2. Appropriate vs. inappropriate antimicrobial therapy;Davey;Clin Microbiol Infect,2008

3. Antibiotic resistance—the need for global solutions;Laxminarayan;Lancet Infect Dis,2013

4. A comprehensive regulatory framework to address the unmet need for new antibacterial treatments;Rex;Lancet Infect Dis,2013

5. Optimising research programmes and infrastructures,2011

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging collaborative research networks against antimicrobial resistance in Asia;Frontiers in Public Health;2023-12-07

2. HNL Dimer in plasma is a unique and useful biomarker for the monitoring of antibiotic treatment in sepsis;2023-08-28

3. Monitoring of sepsis by HNL Dimer in plasma and the comparison with current biomarkers;2023-07-13

4. Riboswitches as therapeutic targets: promise of a new era of antibiotics;Expert Opinion on Therapeutic Targets;2023-06-03

5. Evolution of Antibiotic Resistance in Escherichia coli and Klebsiella pneumoniae Clinical Isolates in a Multi-Profile Hospital over 5 Years (2017–2021);Journal of Clinical Medicine;2023-03-21